CP-673451 is a selective inhibitor of PDGFR/ with IC50 of 10 nM/1 nM in cell-free assays, exhibits >450-fold selectivity over other angiogenic receptors, and has anti-angiogenic and anti-tumor activity.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | CP-673451 |
| Iupac 化学名称 | 1-(2-(5-(2-Methoxyethoxy)benzimidazol-1-yl)quinolin-8-yl)piperidin-4-ylamine |
| 同义词 | CP-673,451; CP-673451; |
| 英文同义词 | CP-673,451; CP-673451; |
| 分子式 | C24H27N5O2 |
| 分子量 | 417.5 |
| Smile | COCCOC1=CC2=C(N(C=N2)C2=NC3=C(C=CC=C3C=C2)N2CCC(CC2)N)C=C1 |
| InChiKey | DEEOXSOLTLIWMG-UHFFFAOYSA-N |
| InChi | InChI=1S/C24H27N5O2/c1-30-13-14-31-19-6-7-21-20(15-19)26-16-29(21)23-8-5-17-3-2-4-22(24(17)27-23)28-11-9-18(25)10-12-28/h2-8,15-16,18H,9-14,25H2,1H3 |
| Cas号 | 343787-29-1 |
| 相关CAS号 | |
| 外观性状 | Solid powder |
| 纯度 | 98% by HPLC |
| 存储 | -20 ºC for 3 years |
| 可溶性 | Soluble in DMSO |
| 处理方式 | |
| 运输条件 | Shipped under ambient temperature |
| 海关编码 | |
| Targets | |
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | |